Article
Total intravenous anesthesia in combination with remimazolam and remifentanil without a neuromuscular blocking agent: a prospective observational study
2022-05-10
Abstract excerpt
<h4>Background: </h4> A novel short-acting benzodiazepine, Remimazolam, has recently been approved for general anesthesia and sedation. Hence, we investigated the feasibility and safety of remimazolam during the induction and maintenance of general anesthesia without using a neuromuscular blocking agent (NMBA) in patients undergoing hysteroscopic surgery. <h4>Methods: </h4>: This prospective observational study in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c3ce8de1-26c4-5b90-9c0f-86492d310eae
- DOI
- 10.21203/rs.3.rs-1551997/v1
